Clinical Trials

Inclusion Criteria

• Provision of written informed consent
• 18 years of age or older
• Has end stage renal disease and has been stable and compliant (as determined by the investigator) on 3 times weekly maintenance hemodialysis for at least 60 days
  • The number of subjects on 3K or higher dialysate will be limited to 60, with the remainder of the subjects on 1K or 2K dialysate
  • Dialysate K must be stable for 2 weeks prior to enrollment
• Hemoglobin > 9 g/dL
• Able to undergo peripheral venous sticks for blood draws on inter-dialysis days, or the dialysis/research team is able to use the dialysis access for blood draws on those days
• Subject or subject's caregiver at home can read and understand English and has the ability to use the BodyGuardian remote monitoring system

Exclusion Criteria

• Pregnancy
• Sexually active women of child-bearing potential must have a negative pregnancy test before starting the study on study day 1
  • Women who are surgically sterile or those who are postmenopausal for at least 2 years are not considered to be of childbearing potential
• Either have or have bed partners with implanted pacemakers or defibrillators
• Have known skin allergies or sensitivities to acrylic, hydrogel or silicone adhesives
• Have fragile skin
• Are participating in another clinical trial which may impact the results of this study
• Subjects who, in the opinion of investigator, are unable to perform the tasks associated with the protocol